"You have helped me explore areas that excite me and i have tried them with my partner."

FOR MEN ONLY: New Clinical Trial Seeks Male Volunteers


Share on Facebook
Share on Twitter
Share on Tumblr
Share on Google Plus
30 August 2016

The primary objective for this study is to evaluate the safety of and record the full effects of a new human growth hormone for men. The study is randomized, vehicle-controlled, ascending multiple dose, placebo-controlled, clinical proof-of-concept, phase 2 study to evaluate the safety, efficacy, tolerability, pharmacokinetics, pharmacodynamics, and physiological effects of Virilimax® administered subcutaneously in adult male patients. Full nudity of volunteers is required.

(Note: All nurse practitioners involved in carrying out the methods of the study are professionals, and any inappropriate behavior by volunteers will not be tolerated. Volunteers will be provided with a digital copy of the 542-page disclosure document listing all possible side effects.)